Notice: This company has been marked as potentially delisted and may not be actively trading. Notable Labs (NTBL) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Notable Labs Pauses Implementation of Cancer Drug Volasertib Study, Announces LayoffsSeptember 20, 2024 | marketwatch.comNotable Labs (NTBL) was downgraded to a Hold Rating at JMP SecuritiesSeptember 20, 2024 | markets.businessinsider.comNotable Labs to Present Data on September 4th at SOHO 2024August 29, 2024 | globenewswire.comNotable Labs Announces CEO TransitionAugust 27, 2024 | finance.yahoo.comNTBL Stock Earnings: Notable Labs Misses EPS for Q2 2024August 16, 2024 | investorplace.comLA’s best burrito is a lab-engineered marvelAugust 15, 2024 | msn.comNotable Labs: Q2 Earnings SnapshotAugust 15, 2024 | sfgate.comNotable Labs, Ltd. (NTBL)July 26, 2024 | finance.yahoo.comNotable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 StudyJuly 24, 2024 | globenewswire.comNPC Labs raises $18M to bring mainstream games to Web3July 22, 2024 | venturebeat.comNTBL Stock Earnings: Notable Labs Misses EPS for Q1 2024May 16, 2024 | investorplace.comBuy Rating Affirmed for Notable Labs Amid Promising Drug Program and Robust PPMP PlatformMay 16, 2024 | markets.businessinsider.comNotable Labs: Q1 Earnings SnapshotMay 15, 2024 | sfgate.comNotable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024May 9, 2024 | globenewswire.comTivic Health, RAPT Therapeutics, Notable Labs among healthcare moversMay 9, 2024 | msn.comNTBL Notable Labs, Ltd.April 30, 2024 | seekingalpha.comCisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For MondayApril 16, 2024 | msn.comBuy Rating for Notable Labs: Financial Stability and Strategic Advances in AML Clinical TrialsApril 15, 2024 | markets.businessinsider.comNTBL Stock Earnings: Notable Labs Misses EPS for Q4 2023April 12, 2024 | investorplace.comNotable Labs Reports 2023 Financial Results and Provides a Business UpdateApril 12, 2024 | globenewswire.comNotable Labs advances cancer treatment with cryopreserved samplesApril 10, 2024 | investing.comNotable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024April 9, 2024 | globenewswire.comNotable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the PlatformApril 8, 2024 | globenewswire.comNotable Labs to Present Two Posters at AACR 2024 on PPMP PlatformMarch 5, 2024 | globenewswire.comNotable Labs to Present Two Posters at AACR 2024 on PPMP PlatformMarch 5, 2024 | globenewswire.comNotable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided EnrollmentFebruary 22, 2024 | finance.yahoo.comNotable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided EnrollmentFebruary 22, 2024 | globenewswire.comMaintained Buy Rating on Notable Labs with Adjusted Price Target Amid Drug Setback and PPMP Platform PotentialDecember 21, 2023 | markets.businessinsider.comNotable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial OutcomeDecember 18, 2023 | finance.yahoo.comNotable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial OutcomeDecember 18, 2023 | finance.yahoo.comNotable Labs Ltd (NTBL)December 14, 2023 | investing.comNotable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic SyndromesDecember 13, 2023 | finance.yahoo.comNotable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 GrantDecember 11, 2023 | finance.yahoo.comNotable Labs to Participate in JMP Securities Hematology and Oncology SummitDecember 4, 2023 | finance.yahoo.comNotable Labs Ltd NTBLNovember 29, 2023 | morningstar.comKeay Nakae’s Buy Rating on Notable Labs: Predictive Precision Medicine Platform and Financial Stability as Key FactorsNovember 21, 2023 | markets.businessinsider.comNotable Labs: Q3 Earnings SnapshotNovember 16, 2023 | washingtonpost.comNotable Labs Announces Filing of Form 10-Q for Third Quarter 2023November 16, 2023 | finance.yahoo.comTrading was temporarily halted for "NTBL" at 01:10 PM with a stated reason of "LULD pause."October 17, 2023 | marketbeat.comTrading was temporarily halted for "NTBL" at 01:10 PM with a stated reason of "LULD pause." Trading set to resume at 01:10 PM. October 17, 2023 | marketbeat.comTrading was temporarily halted for "NTBL" at 10:10 AM with a stated reason of "LULD pause."October 17, 2023 | marketbeat.comTrading was temporarily halted for "NTBL" at 10:10 AM with a stated reason of "LULD pause."October 17, 2023 | marketbeat.com Get Notable Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for NTBL and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast. Click here for the ticker >>> NTBL Media Mentions By Week NTBL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTBL News Sentiment▼0.000.60▲Average Medical News Sentiment NTBL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTBL Articles This Week▼00▲NTBL Articles Average Week Get Notable Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for NTBL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genprex News Mustang Bio News Brainstorm Cell Therapeutics News Aytu BioPharma News Eagle Pharmaceuticals News Viracta Therapeutics News Ensysce Biosciences News Addex Therapeutics News Biofrontera News Coeptis Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTBL) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Notable Labs, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Notable Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
